Abstract
BackgroundNL-201 is a selective and long-acting computationally designed alpha-independent agonist of the IL-2 and IL-15 receptors, which share beta and gamma signaling subunits. NL-201 is being developed as a potent...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have